Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial.
Derick T WadeJames CooperNicholas PeckhamMaurizio BelciPublished in: Clinical rehabilitation (2020)
It is feasible to undertake a larger trial. We recommend broader inclusion criteria to increase eligibility and generalizability.